Maze Therapeutics Inc. (MAZE)
NASDAQ · Healthcare
Maze Therapeutics Inc. annual/quarterly shareholder equity history from 2024 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Maze Therapeutics Inc. shareholder equity for the quarter ending December 31, 2024 were -311.2M.
- Maze Therapeutics Inc. shareholder equity for 2024 were -311.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Maze Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $-311 |
| Maze Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2024-12-31 | $-311 |
Maze Therapeutics Inc. Shareholder Equity — FAQ
Maze Therapeutics Inc. (MAZE) shareholder equity over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MAZE's shareholder equity history?
The chart and table above show Maze Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.